Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 2627 September 2011 and Menton 2011 consensus

Leukemia and Lymphoma

Volumn 53, Issue 10, 2012, Pages 1876-1881

  Meignan, Michel ^a   Gallamini, Andrea ^b   Itti, Emmanuel ^a   Barrington, Sally ^c   Haioun, Corinne ^a   Polliack, Aaron ^d  

^a HENRI MONDOR HOSPITAL   (France)

^b S CROCE E CARLE HOSPITAL   (Italy)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Criteria; Lymphoma; PET; SUV; Trials

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; IFOSFAMIDE; PREDNISONE; RITUXIMAB; VINBLASTINE; VINCRISTINE;

BONE MARROW; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; EVENT FREE SURVIVAL; FRANCE; HODGKIN DISEASE; HUMAN; INTERMETHOD COMPARISON; LARGE CELL LYMPHOMA; LYMPHOMA; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVIEW; SURVIVAL RATE; SURVIVAL TIME; VALIDATION STUDY;

HUMANS; LYMPHOMA; POSITRON-EMISSION TOMOGRAPHY;

EID: 84865752356     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.677535     Document Type: Review

References (7)

1. Meignan M, Gallamini A, Meignan M, et al. Report on the First International Workshop on Interim-PETScan in Lymphoma. Leuk Lymphoma 2009;50:1257-1260.
2. Meignan M, Gallamini A, Haioun C, et al. Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8-9 April 2010. Leuk Lymphoma 2010;51:2171-2180.
3. Haioun C, Itti E, Rahmouni A, et al. [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 2005;106:1376-1381.
4. Gallamini A, Hutchings M, Rigacci L, et al. Early interim 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advancedstage Hodgkin ' s lymphoma: a report from a joint Italian-Danish study. JClin Oncol 2007;25:3746-3752.
5. Barrington SF, Qian W, Somer EJ, et al. Concordance between four European centres of PETreporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Eur JNucl Med Mol Imaging 2010;37:1824-1833.
6. Lin C, Itti E, Haioun C, et al. Early 18F-FDGPETfor prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis. JNucl Med 2007;48:1626-1632.
7. Lin C, Luciani A, Itti E, et al. Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma. Eur Radiol 2011;20:2027-2038.